Predicted protein targets (top 8)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | HTR6 | P50406 | 1/20 | 0.31 |
| ▸ | CHRM5 | P08912 | 1/20 | 0.31 |
| ▸ | ADRA2C | P18825 | 1/20 | 0.31 |
| ▸ | THRB | P10828 | 1/20 | 0.30 |
| ▸ | MEN1 | O00255 | 1/20 | 0.30 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.30 |
| ▸ | HRH3 | Q9Y5N1 | 1/20 | 0.30 |
| ▸ | DPP4 | P27487 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL7870406 | 1.00 | HTR6 (0.31) | HTR6CHRM5ADRA2CTHRBMEN1 | |
| SCHEMBL962787 | 1.00 | HTR6 (0.31) | HTR6CHRM5ADRA2CTHRBMEN1 | |
| SCHEMBL8052849 | 0.95 | ALDH1A1 (0.33) | THRBMEN1KMT2ADPP4 | |
| SCHEMBL31460120 | 0.74 | CYP2D6 (0.36) | MEN1KMT2AHRH3 | |
| SCHEMBL8146446 | 0.72 | HTR6 (0.47) | HTR6 | |
| SCHEMBL633803 | 0.70 | HRH3 (0.36) | MEN1KMT2AHRH3 | |
| SCHEMBL758867 | 0.70 | HTR6 (0.35) | HTR6CHRM5ADRA2CHRH3 | |
| SCHEMBL18768680 | 0.70 | HRH3 (0.36) | MEN1KMT2AHRH3 | |
| SCHEMBL21160967 | 0.70 | HRH3 (0.36) | MEN1KMT2AHRH3 | |
| SCHEMBL11256704 | 0.70 | PHGDH (0.32) | HTR6CHRM5ADRA2CHRH3 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-8138204-B2 | Emesis, dyspepsia, gastroparesis, constipation, gastroesophageal reflux, or post-operative ileus; cisapride analogs; side effect reduction of adverse events; (R)-quinuclidin-3-yl 6-((3S,4R)-4-(4-amino-5-chloro-2-methoxybenzamido)-3-methoxypiperidin-1-yl)hexanoate or salts | ARYX THERAPEUTICS, INC. (US) | 2012-03-20 | — | — | US | claimed |
| US-7282509-B2 | Stereoisomeric compounds and methods for the treatment of gastrointestinal and central nervous system disorders | ARYX THERAPEUTICS (US) | 2007-10-16 | — | — | US | claimed |